ForuMS: Highlights in MS Care from 2022

Credit Available

• Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)™
• Nurses — 1.25 NCPD credit (1.25 in the area of pharmacology)
• Pharmacists — 1.25 contact hours (0.125 CEUs) of continuing pharmacy education credit

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of neurologists, primary care clinicians, advanced practice clinicians, nurses, rehabilitation specialists, mental health specialists, radiologists, pharmacists, and other clinicians who are part of the team that manages patients with MS.

Program Overview

A 75 minute online enduring activity that reviews important information that was presented at the Consortium of Multiple Sclerosis Centers (CMSC) meeting and other meetings, such as the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), as well as key updates to MS care that happened in 2022.

Learning Objectives

At the conclusion of this activity, participants should be better able to:

Review research and advances in the understanding of MS
Discuss new evidence and data related to the treatment and management of MS
Integrate the latest evidence from 2022 into the comprehensive, team-based care of people living with MS in 2023

Faculty

Scott Newsome, DO, MSCS, FAAN, FANA
Past President, Consortium of Multiple Sclerosis Centers
Director, Neurosciences Consultation and Infusion Center
Director, Johns Hopkins Neuroimmunology Clinical Fellowship Program
Co-Director, Multiple Sclerosis Experimental Therapeutics Program
Member, Miller-Coulson Academy of Clinical Excellence
John Hopkins University School of Medicine

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

Credit Designation

Physicians

The CMSC designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
The CMSC designates this activity for a maximum of 1.25 NCPD credit (1.25 in the area of pharmacology).

Pharmacists
This knowledge-based activity, UAN JA4008165-9999-23-020-H01-P qualifies for 1.25 contact hours (.125 CEUs) of continuing pharmacy education credit.

All other health care professionals completing this course will be issued a statement of participation.

Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Continuing Education, CMSC, and Catamount Medical Education require that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies. CMSC and Catamount Medical Education mitigate all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, CMSC and Catamount Medical Education seek to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC and Catamount Medical Education are committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.

Scott Newsome, DO, MSCS, FAAN, FANA

• Consulting Fees: Biogen IDEC; Bristol Myers Squibb; Genentech; Greenwich Biosciences, LLC; Novartis Pharmaceuticals Corporation; EMD Serono
• Contracted Research: Biogen IDEC; Genentech; Roche
• Lead Principal Investigator: Roche clinical trial

Activity Staff Disclosures
June Halper, MSN, APN-C, MSCN, FAAN, and Laurie Scudder, DNP, NP, served as planners and reviewers and have disclosed no relevant financial relationships.

All other planners, reviewers, staff, or other members of the Continuing Professional Education Committee at The Consortium of Multiple Sclerosis Centers who control content have disclosed no relevant financial relationships.

The planners, reviewers, editors, staff, CE committee, or other members at Catamount Medical Education who control content have disclosed no relevant financial relationships

How to Participate in this Activity and Obtain CE Credit

There are no fees for participating and receiving credit for this activity. During the period that the activity is available for credit, participants must:

1. Read the CE information
2. Complete the pretest
3. View the content
4. Complete the posttest and the evaluation form

A score of 75% correct must be achieved on the posttest to successfully complete the activity. If you do not receive a passing score, you will receive a message notifying you that you did not pass the posttest. You may retake the posttest until successful. Upon completion of the evaluation, your certificate will be emailed to you.

This activity is an online enduring material. There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CME information, completing the pre-test, viewing the video, studying the educational activity, and completing the posttest and the evaluation form. Upon completion of the evaluation, your certificate will be made available immediately. Click on “View Certificate” and print the certificate for your records.

This activity was originally released on May 15, 2023 and is eligible for credit through May 15, 2024.